Repotrectinib in ROS1 Fusion–Positive Non–Small-Cell Lung Cancer

Original Article

A. Drilon, D.R. Camidge, J.J. Lin, S.-W. Kim, B.J. Solomon, R. Dziadziuszko, B. Besse, K. Goto, A.J.d. Langen, J. Wolf, K.H. Lee, S. Popat, C. Springfeld, M. Nagasaka, E. Felip, N. Yang, V. Velcheti, S. Lu, S. Kao, C. Dooms, M.G. Krebs, W. Yao, M.S. Beg, X. Hu, D. Moro-Sibilot, P. Cheema, S. Stopatschinskaja, M. Mehta, D. Trone, A. Graber, G. Sims, Y. Yuan, and B.C. Cho

N Engl J Med 2024;390:118-131

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
01/10/2024
Course expires: 
01/11/2026

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Please sign in or create an account to take the course.